US Senators introduce bill to cap insulin prices
In March, the House of Representatives passed a bill that would cap patients’ insulin expenses to USD 35 a month. A new legislative proposal with the same aim has now been revealed by a bipartisan pair of senators.
by christian bundgaard, translated by daniel pedersen
Two US senators have revealed a new bill that would cap patients’ insulin expenses at USD 35 a month, writes industry media Endpoint News.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
US House of Representatives passes bill to cap insulin price
For subscribers
.jpg&w=384&q=75)
